Results 71 to 80 of about 12,522 (168)

Diagnostic challenges in patients with Castleman disease, a single center experience from Hungary

open access: yesPathology and Oncology Research
Castleman disease is a rare and atypical lymphoproliferative disorder characterized by diverse clinical manifestations. It has both unicentric and multicentric forms, the latter with further subdivisions, i.e., human herpesvirus 8-associated and ...
Boglárka Brúgós   +6 more
doaj   +1 more source

Immunophenotypic characteristics of plasma cells in POEMS syndrome

open access: yesCytometry Part B: Clinical Cytometry, Volume 110, Issue 4, Page 266-273, July 2026.
Abstract To analyze the immunophenotypic characteristics of plasma cells in patients with polyneuropathy, organomegaly, endocrinopathy, myeloma protein, and skin changes (POEMS) syndrome. This retrospective study included patients with POEMS syndrome hospitalized in the Department of Hematology, Huashan Hospital, from September 2017 to August 2025 ...
Zhenhua Wang   +6 more
wiley   +1 more source

Refractory Uveitis in Patient with Castleman Disease Successfully Treated with Tocilizumab

open access: yesCase Reports in Ophthalmological Medicine, 2012
Although multicentric Castleman disease is a rare but life-threatening disease, eye complications are extremely uncommon. We present a case of refractory uveitis accompanied with Castleman disease successfully treated with tocilizumab.
Toshiyuki Oshitari   +6 more
doaj   +1 more source

Quantitative analysis of a rare disease network’s international contact database and E-repository provides insights into biobanking in the electronic consent era

open access: yesOrphanet Journal of Rare Diseases, 2019
Background Castleman disease (CD) describes a group of rare and poorly understood lymphoproliferative disorders that include unicentric CD (UCD), Human Herpes Virus-8 (HHV8)-associated multicentric CD (HHV8 + MCD), and HHV8-negative/idiopathic MCD (iMCD).
Alexander Suarez   +2 more
doaj   +1 more source

Update and new approaches in the treatment of Castleman disease

open access: yes, 2016
Kah-Lok Chan,1 Stephen Lade,2 H Miles Prince,1,3 Simon J Harrison1,3 1Department of Haematology, 2Department of Anatomical Pathology, Peter MacCallum Cancer Centre, 3Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC,
Prince HM, Harrison SJ, Chan KL, Lade S
core  

Maladie de castleman multicentrique: A propos d’un cas [PDF]

open access: yes, 2010
La maladie de Castleman est une affection rare, d’étiologie inconnue, caractérisée sur le plan histologique par une hyperplasie lymphoïde angiofolliculaire. Elle se présente sous deux formes différentes, localisée et multicentrique.
M Belcadhi   +19 more
core   +1 more source

P. F. Castleman [PDF]

open access: yes, 1896
R-P of P. Castleman. 17 Mar. SR 498, 54-1, v2, 2p. [3363] or HR 1558, 54-1, v6, 2p.

core   +1 more source

POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein, skin lesions) syndrome: a South America's report POEMS (polineuropatia, organomegalia, endocrinopatia, proteína M, alterações de pele): relato sul-americano

open access: yesArquivos de Neuro-Psiquiatria, 2007
The POEMS syndrome, also known as Crow-Fukase syndrome, is an unusual systemic disorder described mainly in Asian individuals. It is characterized by the presence of (P)polyneuropathy, (O)organomegaly, (E)endocrinopathy, (M) M-protein, and (S) skin ...
Ana Claudia Celestino Leite   +3 more
doaj   +1 more source

Real‐World Usage and Outcomes of Different Siltuximab Dosing Frequency in Idiopathic Multicentric Castleman Disease

open access: yes
American Journal of Hematology, Volume 101, Issue 8, Page 2033-2037, August 2026.
Yoshito Nishimura   +4 more
wiley   +1 more source

Malattia di Castleman

open access: yes, 2020
La malattia di Castleman, una patologia rara che può colpire tutte le età, comprende un gruppo eterogeneo di disordini linfoproliferativi che condividono le stesse caratteristiche istopatologiche.
giona fiorina, mohamed sara
core  

Home - About - Disclaimer - Privacy